Showing 3 posts of 3 posts found.

CymaBay shares results from phase 3 RESPONSE trial for seladelpar

September 8, 2023
Research and Development CymaBay, PBC, Pharmacy, clinical trial, seladelpar

CymaBay Therapeutics has announced positive topline results from its phase 3 RESPONSE study which assessed the safety and efficacy of …

PCTs receive mixed ratings from PBC commissioners

December 14, 2009
PBC, primary

PCTs have received a mixed report from practice-based commissioners, less than a third of who rate the quality of PCT …

Novartis and NHS Alliance collaborate on commissioning guides

July 14, 2009
Sales and Marketing NHS, Novartis, PBC

Novartis has teamed up with the NHS Alliance to launch a series of guides to help practice-based commissioning leaders tackle …

Latest content